Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Br J Dermatol ; 176(2): 431-438, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27718519

RESUMO

BACKGROUND: Rosacea is currently diagnosed by consensus-defined primary and secondary features and managed by subtype. However, individual features (phenotypes) can span multiple subtypes, which has implications for clinical practice and research. Adopting a phenotype-led approach may facilitate patient-centred management. OBJECTIVES: To advance clinical practice by obtaining international consensus to establish a phenotype-led rosacea diagnosis and classification scheme with global representation. METHODS: Seventeen dermatologists and three ophthalmologists used a modified Delphi approach to reach consensus on statements pertaining to critical aspects of rosacea diagnosis, classification and severity evaluation. All voting was electronic and blinded. RESULTS: Consensus was achieved for transitioning to a phenotype-based approach to rosacea diagnosis and classification. The following two features were independently considered diagnostic for rosacea: (i) persistent, centrofacial erythema associated with periodic intensification; and (ii) phymatous changes. Flushing, telangiectasia, inflammatory lesions and ocular manifestations were not considered to be individually diagnostic. The panel reached agreement on dimensions for phenotype severity measures and established the importance of assessing the patient burden of rosacea. CONCLUSIONS: The panel recommended an approach for diagnosis and classification of rosacea based on disease phenotype.


Assuntos
Oftalmopatias/diagnóstico , Rosácea/diagnóstico , Índice de Gravidade de Doença , Idade de Início , Consenso , Efeitos Psicossociais da Doença , Dermatite/etiologia , Dermatologistas , Oftalmopatias/classificação , Humanos , Cooperação Internacional , Estilo de Vida , Oftalmologistas , Planejamento de Assistência ao Paciente , Rosácea/classificação , Pigmentação da Pele/fisiologia , Telangiectasia/etiologia
2.
J Am Acad Dermatol ; 51(4): 499-512; quiz 513-4, 2004 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-15389184

RESUMO

Despite an incomplete understanding of the pathogenesis of rosacea, therapeutic modalities continue to expand. The principal subtypes of rosacea include erythematotelangiectatic rosacea, papulopustular rosacea, phymatous rosacea, and ocular rosacea. These phenotypic expressions are probably caused by divergent pathogenic factors and consequently respond to different therapeutic regimens. A subtype-directed approach to therapy is discussed in part II of this review. We provide an overview of the available topical, oral, laser, and light therapies in the context of these cutaneous subtypes, review the evidence that supports their use, and outline their therapeutic approach. Suggestions for future areas of study also are provided. Learning objective At the completion of this learning activity, participants should be familiar with the subtype-directed approach to therapy for rosacea including available topical, oral, laser, and light therapies.


Assuntos
Rosácea/classificação , Rosácea/terapia , Anti-Infecciosos/economia , Anti-Infecciosos/uso terapêutico , Anticoncepcionais Orais Hormonais/uso terapêutico , Contraindicações , Cosméticos , Custos e Análise de Custo , Fármacos Dermatológicos/economia , Fármacos Dermatológicos/uso terapêutico , Feminino , Humanos , Masculino , Fototerapia , Rosácea/etiologia , Protetores Solares/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA